Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 24, 2024 - Issue 2
Submit an article Journal homepage
965
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Coping with increasing medicine costs through greater adoption of generic prescribing and dispensing in Pakistan as an exemplar country

Saad Abdullaha Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, PakistanView further author information
,
Zikria Saleema Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, PakistanORCID Iconhttps://orcid.org/0000-0003-3202-6347View further author information
ORCID Icon &
Brian Godmanb Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, Pretoria, South Africa;c Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6539-6972View further author information
ORCID Icon
Pages 167-170 | Received 13 Jun 2023, Accepted 03 Nov 2023, Published online: 09 Nov 2023

References

  • Saeed A, Saeed F, Saeed H, et al. Access to essential cardiovascular medicines in Pakistan: a national survey on the availability, price, and affordability, using WHO/HAI methodology. Front Pharmacol. 2021;11:11. doi: 10.3389/fphar.2020.595008
  • United Nations. Transforming our world - the 2030 agenda for sustainable development. Available at url: https://sustainabledevelopment.un.org/content/documents/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf
  • Ozawa S, Shankar R, Leopold C, et al. Access to medicines through health systems in low- and middle-income countries. Health Policy Plann. 2019;34(Supplement_3):iii1–iii3
  • The World Bank. Data for lower middle income, Pakistan. 2023. Available at URL: https://data.worldbank.org/?locations=XN-PK
  • Saeed A, Saeed H, Saleem Z, et al. Evaluation of prices, availability and affordability of essential medicines in Lahore division, Pakistan: a cross-sectional survey using WHO/HAI methodology. PLoS One. 2019;14(4):e0216122. doi: 10.1371/journal.pone.0216122
  • Saleem F, Hassali MA, Iqbal Q, et al. Uncontrollable medicine prices in Pakistan. Lancet. 2016;388(10060):2602
  • Babar Z-U-D. Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan. J Of Pharm Policy And Pract. 2022;15(1):9. doi: 10.1186/s40545-022-00413-3
  • Saeed A, Saeed H, Saleem Z, et al. Impact of national drug pricing policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology. BMJ Open. 2020;10(10):e034720
  • Bhatti M Out of reach - the rising prices of medicines worry consumers. 2023. Available at url: https://www.thenews.com.pk/tns/detail/1067703-out-of-reach
  • Ahmed A Pakistan’s soaring drug prices leave patients scrambling. 24 Oct 2023 Available at URL: https://www.dw.com/en/pakistans-soaring-drug-prices-leave-patients-scrambling/a-67198382
  • Godman B, Fadare J, Kwon HY, et al. Evidence-based public policy making for medicines across countries: findings and implications for the future. J Comp Eff Res. 2021;10(12):1019–1052. doi: 10.2217/cer-2020-0273
  • Garuoliene K, Godman B, Gulbinovič J, et al. European countries with small populations can obtain low prices for drugs: Lithuania as a case history. Expert Rev Pharmacoecon Outcomes Res. 2011;11(3):343–349. doi: 10.1586/erp.11.24
  • Garuolienė K, Godman B, Gulbinovič J, et al. Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies. Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):149–152
  • Markovic-Pekovic V, Skrbić R, Godman B, et al. Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions. Expert Rev Pharmacoecon Outcomes Res. 2012;12(5):661–671
  • Merchant HA, Babar Z-U-D, Hussain IM. A leap towards enforcing medicines prescribing by generic names in low-and middle-income countries (LMICs): pitfalls, limitations, and recommendations for local drug regulatory agencies. J Of Pharm Policy And Pract. 2022;15(1):1–7. doi: 10.1186/s40545-022-00501-4
  • Department of Health, Philippines. Philippine Medicines Policy 2022-2030. Ensuring universal access to medicines and pandemic resiliency. 2023 Available at url: https://pcrp.org.ph/wp-content/uploads/2023/02/Dr.-Fides-PMP-Presentation_v2.pdf
  • Fadare JO, Adeoti AO, Desalu OO, et al. The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):639–650
  • Rasheed H, Hoellein L, Bukhari KS, et al. Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations. J Pharm Policy Pract. 2019;12(1):23. doi: 10.1186/s40545-019-0184-z
  • Masood I, Saleem A, Jamshed SQ. Why do physicians prefer brand medicines over generic medicines in Pakistan? A quantitative approach. J Pharm Health Serv Res. 2016;7(4):247–251. doi: 10.1111/jphs.12152
  • Zaidi S, Bigdeli M, Aleem N, et al. Access to essential medicines in Pakistan: policy and health systems research concerns. PLoS One. 2013;8(5):e63515. doi: 10.1371/journal.pone.0063515
  • Khan N, Naqvi A, Ahmad R, et al. Perceptions and attitudes of medical sales representatives (MSRs) and prescribers regarding pharmaceutical sales promotion and prescribing practices in Pakistan. J Young Pharm. 2016;8(3):244–250
  • Gul B, Sana M, Saleem A, et al. Antimicrobial dispensing practices during COVID-19 and the implications for Pakistan. Antibiotics. 2023;12(6):1018
  • Cadogan CA, Hughes CM. On the frontline against COVID-19: community pharmacists’ contribution during a public health crisis. Res Social Adm Pharm. 2021;17(1):2032–2035. doi: 10.1016/j.sapharm.2020.03.015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.